Standout Papers

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease 2016 2026 2019 2022 573
  1. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease (2016)
    Kenneth I. Ataga, Abdullah Kutlar et al. New England Journal of Medicine

Immediate Impact

23 by Nobel laureates 20 from Science/Nature 70 standout
Sub-graph 1 of 23

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
2 intermediate papers

Works of Jonathan W. Stocker being referenced

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
2016 Standout
Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels
2003

Author Peers

Author Last Decade Papers Cites
Jonathan W. Stocker 785 692 621 19 1.6k
Jan Rosing 195 1218 567 44 2.1k
Vincent Mignotte 398 1356 632 19 2.1k
H. Lum 140 738 280 26 1.9k
Asya V. Grinberg 453 1068 373 38 1.8k
Randal R. Nixon 314 759 492 19 2.0k
C. G. Cochrane 413 430 231 22 1.7k
Lars C. Petersen 157 539 468 36 1.3k
P. Jane Owen‐Lynch 152 450 252 33 1.2k
P.H. Rogers 344 934 63 33 1.8k
Orla Cunningham 228 607 312 36 1.3k

All Works

Loading papers...

Rankless by CCL
2026